We look forward to sharing the knowledge and expertise of this wonderful National Keynote Speaker line up at the 2020 Australian Pain Society 40th Annual Scientific Meeting to be held at the Hotel Grand Chancellor, Hobart this April.
Dr Christine Barry
Dr Christine Barry is a Senior Lecturer in Anatomy and Histology at Flinders University in Adelaide. She is a registered physiotherapist with 20 years clinical experience, including 10 as a Titled Member of Musculoskeletal Physiotherapy Australia, before completing her PhD in 2011 at the University of Adelaide.
Her current research focuses on plasticity of sensory neurons, especially in the female reproductive tract. She was awarded a 2019 Rebecca L Cooper Medical Research Foundation Project Grant to investigate sensory neuron activity and neuron-immune cell interactions relevant to vulvodynia.
Dr Christine Barry will be presenting 2020 Tess Cramond Lecture, discussing Emerging evidence of macrophage contribution to chronic pain associated with the female reproductive tract.
Dr Matthew Bryant
Dr Matthew Bryant (FANZCA, FFPMANZCA, FRACGP, FACRRM, Grad Dip Rural GP, MBBS) is Director of the North Queensland Persistent Pain Management Service. His team of 35 people (25 full time equivalent staff) provide multidisciplinary care to a population of 800 000 people, across five Hospital and Health Services, and an area of 770 000 km2. Prior to obtaining his Pain Medicine and Anaesthesia Fellowships, Matt worked as a rural GP in a number of locations across North Queensland and the Northern Territory. He is currently a Senior Lecturer at James Cook University, and a member of the Townsville Hospital Foundation Board and the ANZCA Faculty of Pain Medicine Queensland Regional Committee. His clinical and research interests include telehealth and pain management for Aboriginal and Torres Strait Islander people.
Dr Kathleen Cooke
After Anaesthesia Fellowship, Dr. Cooke completed her pain medicine training at the Multidisciplinary Pain Management Unit, Royal Brisbane and Women’s Hospital under the mentorship of Professor Tess Cramond. Further studies in paediatric anaesthesia and pain medicine were completed at the Seattle Children’s Hospital, Seattle, USA before returning to Brisbane. She practices paediatric anaesthesia both publicly and privately.
Dr. Cooke practices as a Pain Medicine Specialist at St. Vincent’s Hospital, Brisbane and has a special interest in paediatric, adolescent and young adult pain medicine. She is a Director and Co-founder of SKIP, Support kids in Pain, a not for profit organisation providing community based multidisciplinary pain management programs to support children suffering chronic pain and their families. She is currently the Co-chair of the Statewide Persistent pain Management Network, Queensland.
Dr Andrew Evans
Dr Andrew Evans is a neurologist with more than 15 years specialist experience. He has developed a large team as Director of the Movement Disorder Service, Royal Melbourne Hospital.
He specialises in management and treatment of Parkinson’s patients and other movement disorder patients, offering a range of device-aided therapies to patients with Parkinson’s disease. As a consultant neurologist at the Melbourne Psychiatric Centre, Dr Evans is working within a quaternary referral service providing diagnosis and management of complex patients with a range of neurodegenerative syndromes including application and management of post-operative psychosurgery patients.
Dr Evans’ early research brought to light a range of impulsive and compulsive behaviours in Parkinson’s disease and highlighted the mechanisms underlying these providing critical insight into other behavioural symptoms associated with Parkinson’s disease and disorders of addictions. He has published widely on this and other areas with currently over 100 publications in peer-reviewed journals. He has written 5 books. His current research interests include investigator driven studies for Parkinson’s disease with specific emphasis on identification and management of non-motor symptoms including pain. He has been active in a number of Phase I studies of putative novel neuroprotective agent’s in Parkinson’s.
Dr Cobus Gerber
Dr Cobus Gerber is a senior chemist and heads the Population Health Chemistry research group at the University of South Australia. His research focus is the development of drug recovery from biofluid and wastewater media and mass spectrometry-based detection methods. He collaborates internationally in the emerging field of Wastewater-Based Epidemiology (WBE). He has published several scientific papers and reports for government agencies on the application of WBE to show the scale of use of substances with abuse potential, as well as spatial and temporal changes in drug use in Australia.
Dr Cobus Gerber will be presenting Changes in the scale of opioid consumption and cannabis in Australia by wastewater analysis.
Professor Jennifer Martin
Professor Jennifer Martin is a leading clinical pharmacologist. She is the Chair of the discipline of Clinical Pharmacology in the School of Medicine and Public Health at the University of Newcastle and a senior staff specialist in internal medicine at the John Hunter Hospital.
Professor Martin is also Director of the NHMRC-funded Australia Centre for Cannabinoid Clinical and Research Excellence (ACRE), Australia’s first federally-funded research centre in medicinal cannabinoids to ensure quality and safety in the implementation of medicinal cannabis use in the community.
She is also lead chief investigator on a $1.96 million Cancer Council NSW pathways grant to develop a personalised chemotherapy dosing system for cancer patients, and more than $3m in funding for medicinal cannabis research as part of NSW Government’s Clinical Cannabis Medicines Program. In addition, Professor Martin is part of Australia’s first medical cannabis trial to produce world-class pharmacokinetic analysis and sophisticated modelling to inform drug dosage and frequency of administration.
Based at the Hunter Medical Research Institute, the former Rhodes Scholar leads a team of pharmacy and medicine experts together with pharmacoepidemiologists and pharmacoeconomists.
Professor Jennifer Martin will be presenting the Bonica Lecture.
Professor Michele Sterling
Michele Sterling is Professor in the Recover Injury Research Centre, Program Lead of the Designing Better Therapies research program and Director of the NHMRC Centre of Research Excellence (CRE) in Road Traffic Injury Recovery. She is a Musculoskeletal Physiotherapist and a Fellow of the Australian College of Physiotherapists. She is internationally recognised for her research on whiplash-associated disorders. Michele’s research focusses on the mechanisms underlying the development of chronic pain after injury, predictive algorithms for outcomes and developing effective interventions for musculoskeletal injury and pain. She has received over $13M in research funding from the NHMRC, ARC and industry partners, including 7 NHMRC project grants, 2 CRE’s – the most recent as CIA. She has editorial roles with several leading journals and textbooks, and is a widely published author. She has received numerous awards for her research including the University of Queensland Foundation Research Excellence Award in 2005. Michele is an elected member of the leadership Council of the International Association for the Study of Pain (IASP).
Professor Michele Sterling will be presenting the IASP Global Year Named Lecture.
We are delighted to have this knowledgeable line up of National Keynote Speakers present at the 2020 APS 40th ASM. We hope you will be able to attend and enjoy everything the ASM has to offer.
Registrations are now open!
Follow us on Twitter with: #AusPainSoc @MicheleSterlin7 @DrKathleenCooke #BPRSIG @IASPPain #GlobalYear2020 #IASPGlobalYear #GY2020 #PinCSIG